Insider buying decreased last week with insiders buying $51.96 million of stock compared to $72.32 million in the week prior.

Ligand Pharmaceuticals Incorporated(NASDAQ: LGND)today reported financial results for the three and six months endedJune 30, 2014, and provided an operating forecast and program updates.